09.08.2017 | Original Article
Gefitinib plus Fuzheng Kang’ai Formula (扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial
Erschienen in: Chinese Journal of Integrative Medicine | Ausgabe 10/2018
Einloggen, um Zugang zu erhalten